Neonatal Cardiac Physiology/Pathophysiology/Pulmonary Hypertension

85 - Association between time with open ductus arteriosus and congenital diaphragmatic hernia outcomes

86 - Can Pre-Discharge Oxygen Saturation Metrics Predict Interstage Interval Following Single Ventricle Palliation in Infants with Hypoplastic Left Heart Syndrome?

87 - Cerebral autoregulation impairment in the post-operative period is associated with post-operative length of stay in single ventricle neonates after first surgical palliation

88 - Comparison of Hemodynamic, Gas Exchange and Side Effects of Prostaglandin E1 in Neonates with CHD vs. Pulmonary Hypertension

89 - Digoxin use in congenital diaphragmatic hernia: a review of cases

90 - Ductal Shunting in Neonates with CDH: Does the Direction of Flow Predict Clinical Outcomes?

92 - Inotropic Score and Vasoactive Inotropic Score as Predictors of Outcomes in Congenital Diaphragmatic Hernia: A Single Center Retrospective Study

93 - Postnatal Cerebral Autoregulation and Placental Vascular Malperfusion in Fetuses Diagnosed with Congenital Heart Disease

94 - Prognostic Value of Echocardiographic Parameters in Congenital Diaphragmatic Hernia: A Systematic Review and Meta-analysis

95 - Right ventricular dominance predicts postnatal intervention requirement in those with fetal suspicion of coarctation of the aorta

96 - Sex differences in HIF-related metabolic adaptation in cyanotic congenital heart defects

97 - The Role of DVL2 in Congenital Heart Disease

98 - Usefulness of left pulmonary artery to main pulmonary artery ratio measured by echocardiography for predicting risk of death or ECMO in congenital diaphragmatic hernia

99 - Variability in Hemodynamic Support Practices for Infants with Congenital Diaphragmatic Hernia (CDH) across the Children’s Hospital Neonatal Consortium (CHNC)

100 - Accuracy of NT pro-BNP in Diagnosis of Chronic Pulmonary Hypertension in Extremely Low Gestational Age Neonates

101 - Adenylyl Cyclase Isoform 6 Allosteric Binding Site Can Be Selectively Targeted by Forskolin Derivatives: A Potential Therapeutic Option for Pulmonary Hypertension

102 - Antenatal Vitamin D Treatment Improves Pulmonary Endothelial Cell Function and Response to Proangiogenic Stimuli in a Preeclampsia Model of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension

103 - Characteristics of infants with severe bronchopulmonary dysplasia and pulmonary vein stenosis

104 - Clinical and echocardiographic response to prostaglandin E1 (PGE) infusion for persistent pulmonary hypertension of the newborn (PPHN)

105 - Decreased Micro-RNA 30b Impairs Angiogenesis in Fetal Lambs with Persistent Pulmonary Hypertension Through Altered Notch Signaling

107 - Defining the typical course of PPHN: when to think beyond reversible causes

108 - Impact of Postnatal Dexamethasone on Right Heart Performance in Premature Neonates

109 - Long-term cardiopulmonary effects of ante- and post-natal dexamethasone in adult mice

110 - MiRNA Expression associated with hemodynamically significant intracardiac shunt in low birth weight infants with bronchopulmonary dysplasia and pulmonary hypertension (BPD-PH)

111 - Nintedanib, an Anti-Fibrotic Drug, Preserves Lung Alveolar and Vascular Growth and Prevents Pulmonary Hypertension in an Experimental Model of Hyperoxia-Induced Lung Injury

112 - NO and 100% O2 Can Be a Vasoconstrictive Combination in PPHN Pulmonary Artery

113 - Prediction of pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants using miRNAs in early tracheal aspirate samples

114 - Serial Tissue Doppler Imaging as a tool for screening and diagnosis of bronchopulmonary dysplasia associated pulmonary hypertension in extreme premature infants.

115 - Abnormal amplitude integrated electroencephalography is associated with right ventricular dysfunction in neonates undergoing therapeutic hypothermia for hypoxic ischemic encephalopathy

116 - Blood pressure rather than ductal caliber predicted early pharmacological or spontaneous closure of ductus arteriosus in very preterm infants.

117 - B-type natriuretic peptide assay for individualized pharmacological treatment of patent ductus arteriosus in preterm infants

118 - Early Cardiovascular Physiological Profiling of neonates with Impaired Right Ventricular in the Setting of Hypoxic Ischemic Encephalopathy and Therapeutic Hypothermia.

119 - Impact of Whole Body Hypothermia and Oxygenation on Pulmonary Hemodynamics in MAS, PPHN and HIE.

120 - Impaired right ventricular performance is associated with adverse short term neurological outcome in preterm infants less than 32 weeks of gestational age

121 - Indications and outcomes of neonatal ECMO for hypoxemic respiratory failure in California 2013-20

122 - Left ventricular dimensions and function by three-dimensional echocardiography are associated with brain injury in neonatal encephalopathy

123 - Lung ultrasound score correlates with patent ductus arteriosus shunt volume assessed by echocardiography in very low birth weight infants

124 - Patent ductus arteriosus shunt duration and severity, defined by echocardiography and association with development of severe retinopathy of prematurity in extremely preterm born infants

125 - Prophylactic effects of cyclooxygenase inhibitor on intraventricular hemorrhage: effect modification by risk of intraventricular hemorrhage.

126 - Relationship between lung ultrasound scores and echocardiographic measurements in very low birth weight infants

127 - Remarkable Sexual Dimorphism in the Injured Neonatal Heart: Implications for Prematurity Related Cardiac Outcomes

128 - The Impact of Exclusive Mother’s Own Milk Feeding on Cardiac Performance at 34-36 weeks Postmenstrual Age in Extremely Low Birthweight Infants

129 - Transitional Hypotension in Extremely Premature Neonates and Biomarkers of Brain Injury: Prospective Cohort Pilot Study

209 - Acetaminophen versus Ibuprofen in the management of hemodynamically significant persistent ductus arteriosus in very low birth weight Infants

210 - Assessment of a Hemodynamic PDA with Objective Measures

211 - Association Between Treatment of Patent Ductus Arteriosus and Outcomes Among Extremely Preterm Infants

212 - Contemporary Outcomes of Patent Ductus Arteriosus Closure in Very Low Birth Weight Preterm Infants

213 - Effectiveness and Safety of Acetaminophen for Patent Ductus Arteriosus Treatment in Extremely Low Gestational Age Neonates: A Retrospective Cohort Study

214 - Elevation of IL-6, IL-8, TNF-a, and VEGF is associated with a hemodynamically significant PDA in the first three days of life in extremely premature infants

215 - Failure of Head Growth, but not Weight, is Associated with hsPDA Exposure Among Preterm Infants Born at Less than 27 Weeks Gestation

216 - Genetic Foundation for Responsiveness to Ibuprofen Treatment of Patent Ductus Arteriosus in Extremely Low Birthweight Infants

217 - Impact of neonatal patent ductus arteriosus (PDA) management on neurodevelopment at 5 years of age in children born extremely preterm

218 - Lessons learned from the Implementation of a Percutaneous PDA Closure Program for Preterm infants in a Neonatal Hemodynamics Center

219 - National Trend of Use and Outcomes of Percutaneous Patent Ductus Arteriosus Closure in Newborn Infants

220 - Pharmacological Treatment of Patent Ductus Arteriosus: Comparison of a short versus prolonged strategy

222 - Secular Trends in Patent Ductus Arteriosus Management in Preterm Infants within the Neonatal Research Network

223 - Transcatheter Closure Versus Surgical Ligation of the Patent Ductus Arteriosus: Outcomes in Very Low Birth Weight Infants

224 - Accuracy of the arterial blood pressure waveform measured with catheter-manometer systems in critically ill neonates

225 - Association of Gestational Age at Birth with Left Cardiac Dimensions at Near Term Corrected Age Among Extremely Preterm Infants

226 - Cardiac Alterations in Fetuses Exposed to Rheumatic Disease – A Fetal Speckle Tracking Echocardiography Study.

227 - Early Screening Neonatal Echocardiography for Predicting Treatment of Patent Ductus Arteriosus

229 - Efficacy and Safety of Vasopressin in Newborns with Acute Pulmonary Hypertension

230 - Hemodynamic Profile of Very Low Birth Weight Neonates with Sepsis-Related Hypotension

231 - Impact of Early Screening Echocardiography and Targeted PDA Treatment on Neonatal Outcomes in 22-23 Week Infants

232 - Impact of Targeted Neonatal Echocardiography Service on Assessment and Management of Patent Ductus Arteriosus

234 - Predicting effectiveness of drugs used for treating circulatory failure in preterm infants

235 - Rapid Acquisition of Neonatal Echocardiography Skills Using a Neonatal Echocardiographic Simulator: Will it Affect Transition to Neonatal Echocardiography?

236 - Reliability and bias inherent in the use of angle correction to adjust the Doppler angle for left and right ventricular output.

237 - The Use of Early Continuous Cerebral NIRS Monitoring to Predict Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Infants

238 - Ventricular Function, ECMO Mode, and Outcome in Neonates with Respiratory Failure Treated with ECMO